BioJapan 2026
Dates taking place: 7th – 9th October 2026
Location: PACIFICO Yokohama, Yokohama, Japan
There are biotech partnering events. There are significant biotech partnering events. And then there is BioJapan 2026 — three days at PACIFICO Yokohama where the Asian biotech ecosystem and the global pharmaceutical and biotechnology industry meet for the most concentrated partnering event in the Asia-Pacific calendar.
BioJapan is not a trade show in the conventional sense. It is a partnering event with an exhibition alongside it — the one-to-one meetings between biotech companies, pharmaceutical manufacturers, investors, licensors and licensees that produce the deals, the collaborations and the licensing agreements that the Asian biotech market is generating in increasing volume and that the global industry is paying increasing attention to.
The Japanese biotech ecosystem. The broader Asian market. The global companies that understand that Asia-Pacific is not a peripheral conversation in the pharmaceutical and biotech industry but a central one — and that BioJapan in Yokohama in October is where that conversation is most concentrated and most productive.
BioJapan 2026 runs from the 7th to the 9th of October. Three days. The partnering. The exhibition. The content. Yokohama providing the setting. Yokohama is very good at providing settings.
The Partnering. Which Is the Core.
BioJapan's partnering system is the engine of the event — the scheduled one-to-one meetings between companies that have identified each other as relevant and have come to Yokohama specifically to advance the conversation. Licensing deals. Co-development agreements. Investment discussions. The business relationships between the Japanese biotech ecosystem and the global industry that BioJapan has been facilitating since 1999.
The Japanese pharmaceutical and biotech industry is one of the most significant in the world. The innovation coming from Japanese universities and research institutions. The biotech companies that have been developing assets for years and are now at the stage where global partnerships are the logical next step. The global companies that understand the value of what the Japanese ecosystem is producing and have come to Yokohama to find it.
The meetings scheduled in advance. The conversations prepared for. The three days used with the efficiency of participants who have come a long way and intend to make it worthwhile.
The partnering produces results. BioJapan has been producing them since 1999. The 2026 edition will continue the sequence.
If you need help with your next event, incentive, meeting, conference or group to Japan, please
The Exhibition. The Asian Biotech Ecosystem Visible.
The BioJapan exhibition floor brings together the Japanese and Asian biotech companies — the drug developers, the contract research and manufacturing organisations, the technology platform companies and the service providers that the biotech industry depends on — alongside the international participants who have come to Yokohama to see what the Asian ecosystem is producing.
The Japanese companies presenting their pipelines and their platforms. The Korean and Taiwanese and broader Asian biotech presence that BioJapan attracts beyond its Japanese core. The international pharmaceutical companies whose presence signals the seriousness with which the global industry regards the Asian biotech market.
Walking the floor at BioJapan is walking through the Asian biotech ecosystem at its most visible and most accessible. The companies that are difficult to reach from outside Japan are here. The assets that are in development and not yet widely known are being presented. The platforms that the Japanese research institutions have been building are available for the conversations that the global industry needs to have about them.
The Content. The Asian Biotech Context.
The BioJapan programme covers the biotech and pharmaceutical topics of specific relevance to the Asia-Pacific market and the global companies operating within it. Regulatory pathways in Japan and across the Asian markets. The innovation coming from Japanese and Asian research. The investment landscape for Asian biotech. The partnership models that are producing results in the current environment.
Speakers from inside the Japanese and Asian industry. Regulatory representatives from the PMDA and international agencies. The content that gives the partnering meetings context and that gives the global participants the understanding of the Japanese market that productive partnerships require.
Three days of content built for an audience that is here for the partnering and attends the sessions for the substance they add to it.
Both are worth the time. BioJapan has always understood this.
Yokohama. Which Is Not Tokyo and Is Better for It.
PACIFICO Yokohama sits on the Minato Mirai waterfront — the bay development that has transformed Yokohama's harbour area into one of the most impressive convention and urban districts in Japan. The convention centre. The hotels. The waterfront promenade. The Ferris wheel. The particular quality of a Japanese bay city that has been reinventing itself for decades and has produced something genuinely worth being in.
Yokohama is thirty minutes from Tokyo by train. This is close enough to make Tokyo available for the days around the conference. It is far enough for Yokohama to be entirely itself rather than a suburb of the larger city.
And Yokohama is entirely itself. The Minato Mirai waterfront for the evening walk after the last session. Chinatown — the largest in Japan — for the dinner that earns the deviation from the convention hotel. Motomachi for the shopping street that Yokohama has been maintaining since the port opened to foreign trade in 1859. The harbour that gives the city its character and its history and its particular sense of being open to the world.
October in Yokohama is October in Japan — the autumn colours arriving, the temperatures in the range that makes the city comfortable and the waterfront walk something to do rather than something to endure. The light in October at PACIFICO Yokohama in the early evening has a quality that the waterfront produces in autumn specifically. It is worth being outside for.
The Japanese Biotech Context
Japan is the world's third largest pharmaceutical market. The Japanese biotech industry has been developing assets for decades that the global industry is now actively seeking to partner on. The regulatory environment — the PMDA's willingness to engage early with innovators — has produced a pipeline of assets that the BioJapan partnering event makes accessible to global partners in the most efficient format available.
The Japanese research institutions — the universities, the national institutes, the hospital-based research centres — have been generating science of genuine global significance. BioJapan is where that science meets the global industry. Three days in October. PACIFICO Yokohama. The conversation that both sides have been preparing for.
For DMCs and Incentive Planners: Japan in October With a Purpose
For travel professionals, BioJapan 2026 is the biotech partnering event that combines three days of the most concentrated Asia-Pacific partnering opportunity in the annual calendar with Japan in October — the country in its finest season, the city of Yokohama providing the immediate setting and Tokyo thirty minutes away for the itinerary that wants both.
The pre-event arrival that uses Japan properly. Tokyo for the days before BioJapan begins — the city, the food, the culture, the particular quality of Japan in October when the autumn colours are arriving and the temperature is exactly right. Yokohama for the conference days and the waterfront evenings. The extension that Japan in October justifies for any client who has come this far.
For incentive groups within the biotech and pharmaceutical sector, BioJapan 2026 provides the professional substance of the most focused Asian biotech partnering event in the calendar alongside Japan in October. The country, the culture, the food and the particular quality of a Japanese city in autumn that no European or American convention destination approaches.
The partnering is at PACIFICO Yokohama. Japan is everywhere else. Both are worth the journey.
October in Japan. The biotech industry finding what it came for. Yokohama providing everything around it.
Both reliable. Both worth the considerable journey required to be there.
For more information about the event visit this page.
If you would like to see more events like these visit our events page!
Disclaimer:
We have researched the dates of this event for you. However, before you plan and book, please always check with the event organiser directly to see if there have been any changes and if the event still takes place.
